Canada markets close in 4 hours 29 minutes

NOXXON Pharma N.V. (ALNOX.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
0.0497-0.0069 (-12.19%)
At close: 05:16PM CEST
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
1,029
982
Gross Profit
-
-
-
-1,029
-982
Operating Expenses
Research Development
10,657
10,657
4,017
496
479
Selling General and Administrative
1,265
1,265
912
1,320
1,292
Total Operating Expenses
13,451
13,451
5,751
2,915
3,337
Operating Income or Loss
-13,451
-13,451
-5,751
-3,944
-4,319
Interest Expense
1,504
1,504
5,055
3
6,758
Income Before Tax
-14,452
-14,452
-10,406
-860
-10,737
Income Tax Expense
1
1
0
1
1
Income from Continuing Operations
-14,453
-14,453
-10,406
-861
-10,738
Net Income
-14,452
-14,452
-10,405
-861
-10,734
Net Income available to common shareholders
-14,452
-14,452
-10,405
-861
-10,734
Basic EPS
-
-
-0.32
-0.08
-2.70
Diluted EPS
-
-
-0.32
-0.08
-2.70
Basic Average Shares
-
-
32,359
11,158
3,979
Diluted Average Shares
-
-
32,359
11,158
3,979
EBITDA
-
-12,882
-5,288
-810
-3,956